Oxford Biomedica PLC Director Shareholding (8646W)
April 29 2016 - 8:35AM
UK Regulatory
TIDMOXB
RNS Number : 8646W
Oxford Biomedica PLC
29 April 2016
Oxford BioMedica plc Director's Share Purchase
Oxford, UK - 29 April 2016: Oxford BioMedica plc ("Oxford
BioMedica" or "the Group") (LSE: OXB), a leading gene and cell
therapy group, was informed that on 29 April 2016 one of its
Directors acquired ordinary shares of 1p each ("Ordinary Shares")
as follows:
Interest after
purchase
------------ ---------- ---------- ---------------- ----------------------------
Director Title Price Number of Number % of total
/ PDMR per share Ordinary Shares of Ordinary issued
(p) acquired Shares share capital
------------ ---------- ---------- ---------------- ------------ --------------
Executive
Peter Nolan director 5.5567p 359,925 1,401,968 0.05%
------------ ---------- ---------- ---------------- ------------ --------------
The issued share capital of the Group is 2,702,901,494 1p
ordinary shares.
- Ends -
For further information, please
contact:
Oxford BioMedica plc: Tel: +44 (0)1865
John Dawson, Chief Executive Officer 783 000
Tim Watts, Chief Financial Officer
Consilium Strategic Communications Tel: +44 (0)20
Mary-Jane Elliott/Matthew Neal/Chris 3709 5700
Welsh/Laura Thornton
Notes for editors
About Oxford BioMedica(R)
Oxford BioMedica (LSE:OXB) is a leading gene and cell therapy
company focused on developing life changing treatments for serious
diseases. Oxford BioMedica has built a sector leading lentiviral
vector delivery platform (LentiVector(R) ) through which the Group
develops in vivo and ex vivo products both in-house and with
partners. The Group has created a valuable proprietary portfolio of
gene and cell therapy product candidates in the areas of oncology,
ophthalmology and CNS disorders. The Group has also entered into a
number of partnerships, including with Novartis, Sanofi, GSK, and
Immune Design, through which it has long-term economic interests in
other potential gene and cell therapy products. Oxford BioMedica is
based across several locations in Oxfordshire, UK and employs more
than 230 people. Further information is available at
www.oxfordbiomedica.co.uk.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHUKOURNOASUAR
(END) Dow Jones Newswires
April 29, 2016 08:35 ET (12:35 GMT)
Oxford Biomedica (LSE:OXB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Oxford Biomedica (LSE:OXB)
Historical Stock Chart
From Apr 2023 to Apr 2024